Hernexeos Patient Assistance Program

(zongertinib)

Key Takeaways

  1. Hernexeos® (zongertinib) is a prescription targeted cancer therapy used to treat certain adults with unresectable or metastatic HER2-mutated non-small cell lung cancer (NSCLC).
  2. Hernexeos works by blocking abnormal HER2 (ERBB2) signaling that drives the growth and survival of certain lung cancer cells.
  3. Because Hernexeos targets a specific genetic mutation, patients must undergo FDA-approved companion diagnostic testing to confirm HER2 (ERBB2) tyrosine kinase domain activating mutations before treatment.
  4. Prescription Hope may help eligible individuals access manufacturer-sponsored patient assistance programs that can make Hernexeos more affordable.

 

Introduction

Receiving a diagnosis of advanced non-small cell lung cancer (NSCLC) often means navigating complex treatment decisions. Advances in precision medicine have made it possible to identify specific genetic mutations that may respond to targeted therapies, allowing some patients to receive treatments designed to the biology of their cancer.

Hernexeos is a targeted therapy approved for adults with unresectable or metastatic non-squamous NSCLC whose tumors have HER2 (ERBB2) tyrosine kinase domain activating mutations confirmed by an FDA-approved companion diagnostic test. By targeting the abnormal HER2 protein that drives cancer cell growth, Hernexeos may help slow disease progression and shrink tumors in eligible patients.

As a newly approved specialty oncology medication, Hernexeos can be expensive depending on insurance coverage and specialty pharmacy pricing. Many patients researching the Hernexeos patient assistance program are looking for ways to reduce out-of-pocket medication costs while maintaining access to treatment.

Prescription Hope offers qualified patients access to the Hernexeos Patient Assistance Program, which provides Hernexeos at affordable rates.

What Is the Hernexeos Patient Assistance Program?

Understanding Hernexeos Prescription Assistance

While researching where to find affordable Hernexeos, some patients may have come across the Hernexeos patient assistance program.

This leaves the question: what is a patient assistance program? Pharmaceutical manufacturers recognize that their medications can be too expensive for some Americans to pay out of pocket, while alternatives like inadequate insurance and gaps in government coverage leave patients vulnerable to high medication prices.

Patient medication assistance programs offer qualified patients access to the brand-name medication they need at a more affordable cost. The only problem is that the application process for these assistance programs is known to be tedious, involving lots of paperwork and requiring consistent communication with healthcare providers and pharmaceutical manufacturers.

Thankfully, Prescription Hope is here to help you obtain Hernexeos financial assistance at a low rate, and with peace of mind.

How Expert Advocates Help Make Hernexeos More Affordable

Personalized Medication Assistance

Prescription Hope’s Hernexeos patient assistance program offers medication advocate support to qualified individuals throughout the application process and even after approval. Our team of patient advocates offers Hernexeos application help, including form completion, document and signature collection, coordinating with healthcare providers and medication manufacturers, and more.

Ongoing Patient Support

Not only does our team of patient advocates help you with the application process, but they also offer long-term medication assistance as long as you are a patient with Prescription Hope.

Our specialty oncology support offers refill scheduling, document updates, yearly renewals, program monitoring, all for treatment continuity.

Hernexeos Price Comparison

vs

Prescription Hope logo

Estimated Retail Price*

$10,590.07

30-Day Supply

Prescription Hope Price

$70

Per Month, NO Matter The Retail Price

*Source: Drugs.com

Navigating Lung Cancer Treatment Costs

While lung cancer treatment can be incredibly harrowing both to a patient’s well-being and their finances, your prescription access solutions don’t have to be. Out-of-pocket expenses can overwhelm a patient; insurance can include high co-pays or deductibles, discount cards and coupons may only offer limited savings, and government programs can include large gaps.

Prescription Hope is different. We don’t cut corners to help you save; we are not a coupon card, and we are not government-affiliated.

We are a medication access service that offers access to affordable name-brand medications for $70.00 per medication, per month. We do not charge hidden fees, add-ons, or medication costs.

If you don’t qualify for the medication you need, we will help you find alternatives such as substitute medications, discount cards, coupons, or other ways to save.

If we can’t help you save, you pay nothing!

Hernexeos Patient Assistance Eligibility

General Eligibility Requirements

Patients interested in who qualifies for Hernexeos assistance will need to understand the prescription assistance requirements. All patient assistance programs have criteria for medication assistance eligibility, so patients should know if they are likely to qualify.

Programs will often set requirements in several categories, such as:

Income: Each program sets its own income requirement for the patient to qualify.

Insurance: Each program also sets its own requirements for the patient’s insurance coverage status.

Prescription: All patients must have a valid prescription for their intended brand-name medication from the patient’s practitioner to qualify.

U.S. Residency: All patients must be legal U.S. citizens to qualify.

Simple Enrollment With Expert Support

Getting Started With Enrollment

Are you ready to enroll in Hernexeos assistance? Are you daunted by the Hernexeos application process? Applying to Prescription Hope’s patient assistance registration only takes 6 simple steps:

  1. Submit Information: Our online enrollment form can be completed within just a few minutes.
  2. Advocate Contact: Once your application is submitted, you will be contacted by a patient advocate within 1-2 business days.
  3. Document Collection: After prequalification, our team will collect all the necessary documents.
  4. Provider Coordination: Our team will also gather any needed signatures from your healthcare providers.
  5. Program Submission: Once everything is collected, we will submit your application on your behalf and continue to coordinate with the pharmaceutical manufacturer through the processing phase of your application.
  6. Medication Delivery: After the approval goes through, patients usually receive their medication in 2 weeks.

Prescription Hope is not a pharmacy or manufacturer, and therefore does not handle medication directly. All medications are shipped directly from the manufacturer to the patient’s door or their healthcare provider’s office.

Understanding Hernexeos

How Hernexeos Works

Hernexeos is a tyrosine kinase inhibitor (TKI) that targets the human epidermal growth factor receptor 2 (HER2), also known as ERBB2. In certain people with non-small cell lung cancer, activating mutations in the HER2 gene cause cancer cells to grow and divide uncontrollably.

Hernexeos selectively blocks the abnormal HER2 tyrosine kinase, interrupting signaling pathways that promote cancer cell growth and survival. By inhibiting these signals, the medication may help slow tumor growth and cause tumors to shrink in eligible patients.

Because Hernexeos specifically targets HER2-mutated cancer cells, treatment is intended only for patients whose tumors have confirmed HER2 (ERBB2) tyrosine kinase domain activating mutations identified through an FDA-approved companion diagnostic test.

What Conditions Does Hernexeos Treat?

Hernexeos is FDA-approved for the treatment of adults with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) whose tumors have HER2 (ERBB2) tyrosine kinase domain activating mutations detected by an FDA-approved companion diagnostic test.

This indication received accelerated approval from the FDA, meaning continued approval may depend on confirmation of clinical benefit in additional studies.

Hernexeos is intended for patients whose lung cancer cannot be removed surgically or has spread to other parts of the body. Because the medication targets a specific genetic mutation, biomarker testing is required before treatment to determine whether a patient is eligible to receive this therapy.

Benefits of Treatment

Hernexeos provides a targeted treatment option for patients with HER2-mutated non-small cell lung cancer by addressing one of the genetic drivers of tumor growth. Unlike traditional chemotherapy, it is designed to selectively inhibit abnormal HER2 signaling involved in cancer cell survival.

Potential benefits include shrinking tumors, slowing the progression of advanced lung cancer, improving disease control, and providing an oral treatment alternative to intravenous cancer therapies. Because it is taken by mouth once daily, Hernexeos also offers the convenience of at-home administration for eligible patients.

Treatment outcomes vary among individuals. Healthcare providers routinely monitor treatment response, side effects, and overall disease status throughout therapy to determine whether treatment should continue or be modified.

Important Safety Information and Side Effects

Hernexeos does not carry an FDA Boxed Warning.

The most commonly reported side effects include diarrhea, rash, muscle or joint pain, fatigue, nausea, decreased appetite, dry skin, nail changes, mouth sores (stomatitis), increased liver enzyme levels, and COVID-19 infection. Patients should notify their healthcare provider if side effects become severe, persistent, or difficult to manage.

Hernexeos may cause liver injury (hepatotoxicity). Healthcare providers typically monitor liver function tests, including ALT, AST, and bilirubin, before treatment begins and periodically throughout therapy. Patients should promptly report symptoms such as yellowing of the skin or eyes, dark urine, persistent nausea or vomiting, or severe fatigue.

Serious and potentially fatal interstitial lung disease (ILD) or pneumonitis has occurred during treatment. Patients should immediately report new or worsening cough, shortness of breath, fever, or difficulty breathing. Depending on severity, treatment may need to be interrupted or permanently discontinued.

Hernexeos may reduce the heart’s pumping ability, resulting in left ventricular dysfunction. Healthcare providers may assess cardiac function before and during treatment, particularly in patients with existing cardiovascular risk factors.

Based on its mechanism of action, Hernexeos may cause fetal harm if used during pregnancy. Patients who can become pregnant should use effective contraception during treatment and for the recommended period after the final dose. Male patients with partners who can become pregnant should also follow recommended contraception guidance.

Hernexeos may interact with medications that strongly affect CYP3A enzyme activity, including strong CYP3A inhibitors and strong or moderate CYP3A inducers. These interactions may alter zongertinib blood levels and affect treatment safety or effectiveness. Patients should inform their healthcare provider about all prescription medications, over-the-counter medicines, vitamins, and herbal supplements before starting treatment.

Hernexeos is taken orally once daily and may be taken with or without food. The dose is determined by body weight, and treatment generally continues until disease progression or unacceptable toxicity occurs. Tablets should be swallowed whole and taken at approximately the same time each day. Patients should follow their healthcare provider’s instructions regarding missed doses or vomiting after a dose and should never adjust or discontinue treatment without consulting their oncology care team.

Healthcare providers typically monitor liver function, signs and symptoms of interstitial lung disease or pneumonitis, cardiac function when clinically appropriate, treatment response, and adverse reactions that may require dose modification.

Access to Multiple Medications

Support Beyond Hernexeos

Cancer patients often need multiple medications during the course of their treatment, and often search for multiple medication assistance programs.

Prescription Hope can help with multiple prescription affordability services for hundreds of brand-name medications. No matter how many medications you need during your lung cancer medication assistance, we provide the same great service at the low price of $70.00 per medication, per month.

Why Choose Prescription Hope for Hernexeos Assistance

Patient-Focused Medication Support

For the last two decades, Prescription Hope has offered patient-centered assistance and prescription affordability support for patients all over the nation. Our medication access specialists help Americans from rural areas to the big cities access the medications they need at a low cost.

Simplified Access to Specialty Therapies

Our service rate is simply $70.00 per month, per medication. There are no hidden fees, add-ons, medication fees, or service charges. If we can’t help you find a way to save, then you pay nothing!

Ongoing Prescription Assistance

We don’t just offer assistance with prescription affordability program applications. We offer long-term medication support, such as yearly renewals, prescription refills, document updates, program monitoring, and more.

Network Access

Our network spans all across America, allowing patients from coast to coast and all in between to get the name-brand medications they need at a reasonable rate.

If you’re looking for treatment affordability solutions and affordable Hernexeos access, enroll with Prescription Hope to get started today!

 

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!